Recursion Pharmaceuticals Publicly Traded Corporation

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.


Connections from

Total Funding: 865376000
Founded Date: 2013-11-05
Employee Number: 501-1000
Last Funding Date: 2024-06-26
Headquarters: Salt Lake City,Utah,United States,North America
Funding Stage: IPO
Funding Total Value: 865376000
Last Funding Total Usd: 200000000
Last Funding Total Currency: USD
Last Funding Total Value: 200000000
Founders: Blake Borgeson,Christopher Gibson,Dean Li
Phone Number: 385-269-0203
Stock Symbol: RXRX
City: Salt Lake City
Region: Utah
Country: United States